InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.550
-0.220 (-7.94%)
Jun 11, 2025, 4:00 PM - Market closed
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $3.08 million as of June 11, 2025. Its market cap has increased by 18.40% in one year.
Market Cap
3.08M
Enterprise Value
-793.49K
1-Year Change
18.40%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $3.08M, a decrease of -88.16%. That is a compound annual growth rate of -37.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 3.30M | -2.94% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.69B |
| Johnson & Johnson | 374.96B |
| AbbVie | 336.06B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 274.86B |
| Abbott Laboratories | 232.70B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |